All posts tagged
Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment
Scottish Biotech and Bluebird Bio to Develop Next Generation CAR-T Cells
Meet the CEO Leading Italy’s Charge to Become a Major Biotech Player
This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected
More News! Novartis is going for EMA Approval for CAR-T Therapy
Update: Clinical Holds Lifted for First Off-the-Shelf CAR-T Therapy
The FDA Approves a Second CAR-T Therapy, Cheaper than Novartis’
Infographic: What is CAR-T Cell Therapy & How Does it Fight Cancer?
Belgian Biotech’s Leukemia CAR-T Treatment Leaves Patient Cancer-Free
British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies
CAR-T is Nearly Here: How Will It Be Delivered?
The CAR-T Race is Far from Over: This CEO is Exploring a New Avenue
Labiotech UG, All Rights Reserved -
Send this to a friend